FKBP1AP1

Across TCGA pan-cancer cohorts, FKBP1AP1 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated FKBP1AP1 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher FKBP1AP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FKBP1AP1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and UCEC show a favorable association.

THCA, CHOL, and LGG are the cancer types where FKBP1AP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Quartile	IV	0.408	0.934	.003	52	view →
CHOL	OS	Tertile	III,IV	0.162	0.915	.004	45	view →
LGG	DFS	Median	All	0.682	0.793	.002	29	view →
KIRC	DFS	Median	III,IV	0.739	0.520	.009	22	view →
PAAD	OS	Quartile	II,III,IV	0.318	0.670	.018	21	view →
LIHC	DFS	Median	All	0.481	0.596	.008	19	view →
ESCA	OS	Median	All	0.418	0.577	.021	14	view →
UCEC	DFS	Median	IV	0.878	0.452	<.001	14	view →
TGCT	DFS	Quartile	All	0.459	0.773	.021	12	view →
READ	OS	Tertile	III,IV	0.591	1.000	.010	12	view →
UVM	DFS	Quartile	All	0.508	1.000	.007	11	view →
SKCM	DFS	Tertile	All	0.537	0.693	.008	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

FKBP1AP1–THCA (DFS)

Open the THCA breakdown →